Simultaneous quantitation of rosiglitazone and glibenclamide in human plasma by LC-MS/MS; method development and validation

Research Journal of Biotechnology

Volumn 3, Issue SPEC. ISS., 2008, Pages 414-418

  Sengupta, Pinaki ^a   Das, Ayan ^a   Chatterjee, Bappaditya ^a   Bhaumik, Uttam ^a   Ghosh, Animesh ^a   Bose, Anirbandeep ^a   Pal, T K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Glibenclamide; Human plasma; LC MS MS; Method validation; Rosiglitazone

Indexed keywords

EID: 61549130309     PISSN: 09736263     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Singamsetty Radha Krishna, Mandava Venkata Naga Brahmeshwar Rao, Tirmalaraju Satyanaryana Raju, Vurimidi Himabindu And Ghanta Mahesh Reddy, Isolation, Synthesis and Characterization of Rosiglitazone Maleate Impurities, E-Journal of Chemistry, 5(3), 562 (2008).
2. Hennessey J. V., Bustamante M. A., Teter M. L., Bedtime dosing of glyburide and the treatment of type II diabetes mellitus, Amer J Med Sci, 308, 234 (1994).
3. Kreider M., Miller E., Patel J., Rosiglitazone (RSG) is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T22DM), Diabetes, 48(1), 117 (1999).
4. Jahanvi N. Jingar, Sadhna J. Rajput, Bhavesh Dasandi, Shivprakash Rathnam, Development and Validation of LC-UV for Simultaneous Estimation of Rosiglitazone and Glimepride in Human Plasma, Chromatographia., 67, 951 (2008).
5. Jaber L. A., Antal E. J., Welshman I. R., Pharmacokinetics and pharmacodynamics of gl yburide in young and elderly patients with non-insulin-dependent diabetes mellitus, Ann Pharmacother, 30, 472 (1996).
6. Rajendran S. D., Philip B. K., Gopinath R., Suresh B., RPHPLC method for the estimation of glibenclamide in human serum, Indian journal ofpharmaceurical sciences, 69(6), 796 (2007).
7. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001, Centre for Veterinary Medicine (CV), May 2001. http://www/fda.gov/cder/guidance/index.htm.